Related Experiment Videos
Addiction pharmacotherapy 2000: new options, new challenges
R A Rawson1, M J McCann, A J Hasson
1UCLA Integrated Substance Abuse Programs, Los Angeles, California 90025, USA.
Journal of Psychoactive Drugs
|February 24, 2001
Summary
Advances in addiction pharmacotherapy are improving substance abuse treatment. New medications for alcoholism and opiate dependence offer better access and effectiveness, with ongoing research for stimulant addiction treatments.
Area of Science:
- Pharmacology
- Addiction Medicine
- Neuroscience
Background:
- Substance abuse research and treatment integration is advancing.
- Pharmacotherapy plays a crucial role in this evolution.
- Current treatments are expanding for various substance use disorders.
Purpose of the Study:
- To highlight the impact of pharmacotherapy advancements on substance abuse treatment.
- To discuss the current and emerging medication options for alcoholism, opiate dependence, and stimulant addiction.
- To emphasize the importance of integrating new treatments into standard care.
Main Methods:
- Review of current pharmacotherapies for substance abuse.
- Discussion of newly approved and developing medications.
- Analysis of the potential impact of these advancements on patient access and treatment effectiveness.
Main Results:
- Alcoholism treatment now includes disulfiram, naltrexone, and soon acamprosate.
- Opiate dependence treatment has expanded with LAAM and anticipated buprenorphine/naloxone availability outside traditional settings.
- Research is actively pursuing medications for stimulant addiction, including cocaine and methamphetamine.
Conclusions:
- Pharmacotherapy advancements are significantly improving substance abuse treatment options.
- The integration of new medications promises enhanced access and effectiveness of care.
- Continued research and adoption of these treatments are vital for patient recovery.